[Form 4] Palantir Technologies Inc. Insider Trading Activity

Rhea-AI Filing Summary

Palantir (PLTR) Chief Financial Officer David A. Glazer reported multiple transactions on September 2, 2025, executed under a preexisting Rule 10b5-1 trading plan.

The reporting person exercised an aggregate of 37,770 vested stock options (26,513 and 11,257) with an exercise price of $4.72 and immediately sold those shares along with 43,230 additional shares in open-market trades on the same date. The reported sales were executed across price ranges from $150.42 to $158.11, with several weighted-average prices shown for different tranches. The filings show the reporting person owned 500,912 shares before the series of transactions and 431,169 shares following the reported sales.

Positive

• Transactions executed pursuant to a preexisting Rule 10b5-1 trading plan, providing an affirmative defense and signaling preplanned activity
• Exercised options were fully vested, as explicitly stated in the filing
• Filing includes detailed footnotes with price-range disclosures and an offer to provide tranche-level sale details upon request

Negative

• Substantial insider selling: an aggregate of 81,000 shares were sold on September 2, 2025, reducing beneficial ownership from 500,912 to 431,169 shares
• Material reduction in holdings by CFO could be perceived as noteworthy by investors given the size of the sales

Insights

Securities Analyst

Insider exercised vested options and sold a meaningful block under a 10b5-1 plan; transactions appear procedural rather than unusual.

The Form 4 discloses that the CFO exercised 37,770 fully vested employee stock options at $4.72 and sold those shares plus 43,230 additional shares in multiple open-market trades on September 2, 2025, resulting in reported proceeds across price bands of roughly $150 to $158 per share. The use of a preexisting Rule 10b5-1 plan (entered June 3, 2025) is explicitly noted, which provides an affirmative defense for trades executed pursuant to a predetermined schedule. The filing quantifies the post-transaction beneficial ownership decline from 500,912 to 431,169 shares, and indicates 223,487 options remain reported in Table II after these exercises. For investors, this is a clear disclosure of option exercise and substantial selling by a senior officer, documented as plan-driven rather than ad hoc.

Corporate Governance Expert

Disclosure aligns with Section 16 reporting norms; 10b5-1 plan use and explicit footnotes improve transparency.

The Form 4 includes detailed footnotes describing price ranges for multiple tranches of open-market sales and affirms that the exercised options were fully vested as of the transaction date. The reporting person also commits to provide detailed trade-by-trade pricing to SEC staff or shareholders upon request, which enhances disclosure quality. The filing includes the officer's title (Chief Financial Officer and Treasurer) and a cross-reference to the proxy statement for fuller ownership context. From a governance perspective, these elements support compliance and transparency while documenting a material reduction in beneficial holdings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glazer David A.

(Last) (First) (Middle)

C/O PALANTIR TECHNOLOGIES INC.

1200 17TH STREET, FLOOR 15

(Street)

DENVER CO 80202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Palantir Technologies Inc. [ PLTR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/02/2025		M		26,513	A	$4.72	500,912	D
Class A Common Stock	09/02/2025		M(1)		11,257	A	$4.72	512,169	D
Class A Common Stock	09/02/2025		S(1)		200	D	$150.85(2)	511,969	D
Class A Common Stock	09/02/2025		S(1)		27,500	D	$152.1807(3)	484,469	D
Class A Common Stock	09/02/2025		S(1)		700	D	$153.2229(4)	483,769	D
Class A Common Stock	09/02/2025		S(1)		500	D	$154.322(5)	483,269	D
Class A Common Stock	09/02/2025		S(1)		38,500	D	$155.2068(6)	444,769	D
Class A Common Stock	09/02/2025		S(1)		4,631	D	$156.5673(7)	440,138	D
Class A Common Stock	09/02/2025		S(1)		8,569	D	$157.3661(8)	431,569	D
Class A Common Stock	09/02/2025		S(1)		400	D	$158.0775(9)	431,169	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to buy)	$4.72	09/02/2025		M(1)			11,257	(10)	06/03/2030	Class A Common Stock	11,257	$0	0	D
Employee Stock Option (Right to buy)	$4.72	09/02/2025		M(1)			26,513	(10)	06/03/2030	Class A Common Stock	26,513	$0	223,487	D

Explanation of Responses:

1. This transaction is part of a related series of transactions undertaken on September 2, 2025 pursuant to a preexisting Rule 10b5-1 trading plan, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), entered into on June 3, 2025. The Reporting Person exercised an aggregate of 37,770 vested Class A Common Stock options and immediately sold the shares of Class A Common Stock along with 43,230 additional shares of Class A Common Stock in the open market.

2. This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $150.42 to $151.28. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (9) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

3. This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $151.84 to $152.47. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (9) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

4. This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $152.91 to $153.71. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (9) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

5. This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $153.99 to $154.64. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (9) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

6. This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $155.01 to $155.98. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (9) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

7. This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $156.02 to $157.00. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (9) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

8. This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $157.02 to $158.00. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (9) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

9. This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $158.02 to $158.11. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (9) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

10. The options exercised in this transaction were fully vested and exercisable as of the transaction date.

Remarks:

Officer title: Chief Financial Officer and Treasurer. This Form 4 has been compiled based on applicable requirements to reflect the specific transactions described herein and is not intended to disclose or describe all shares and/or other equity securities owned or beneficially held by the Reporting Person. For additional details regarding the Reporting Person's overall stock and equity holdings, please see the Issuer's Proxy Statement filed with the Securities and Exchange Commission on April 25, 2025, including under the heading "Security Ownership Of Certain Beneficial Owners And Management" (subject to the definitions, explanations, and time periods described therein).

	/s/ Justin V. Laubach, under power of attorney	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did PLTR CFO David Glazer do on September 2, 2025?

He exercised 37,770 vested options at a $4.72 exercise price and sold those shares plus 43,230 additional shares in open-market transactions conducted under a Rule 10b5-1 plan.

How many PLTR shares did the reporting person own after these transactions?

The Form 4 reports 431,169 shares of Class A Common Stock owned following the reported transactions.

At what prices were the PLTR shares sold?

Sales were executed in multiple tranches with price ranges between $150.42 and $158.11; weighted-average prices for tranches are provided in the filing footnotes.

Was the sale part of a 10b5-1 trading plan?

Yes. The transactions were undertaken pursuant to a preexisting Rule 10b5-1(c) trading plan entered into on June 3, 2025.

Were the exercised options vested?

Yes. The filing states the options exercised on September 2, 2025, were fully vested and exercisable as of the transaction date.